List of Tables
Table 1. Global Cancer Biomarkers Sales (K MT) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Cancer Biomarkers Sales (K MT) Comparison by Application: 2020 VS 2026
Table 3. Global Cancer Biomarkers Market Size by Type (K MT) (US$ Million) (2020 VS 2026)
Table 4. Global Key Cancer Biomarkers Manufacturers Covered in This Study
Table 5. Global Cancer Biomarkers Sales (K MT) by Manufacturers (2015-2020)
Table 6. Global Cancer Biomarkers Sales Share by Manufacturers (2015-2020)
Table 7. Global Cancer Biomarkers Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Cancer Biomarkers Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Cancer Biomarkers Average Price (USD/MT) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Cancer Biomarkers Sales Sites and Area Served
Table 11. Manufacturers Cancer Biomarkers Product Types
Table 12. Global Cancer Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Cancer Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biomarkers as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Cancer Biomarkers Players
Table 16. Global Cancer Biomarkers Sales (K MT) by Region (2015-2020)
Table 17. Global Cancer Biomarkers Sales Market Share by Region (2015-2020)
Table 18. Global Cancer Biomarkers Revenue (Million US$) by Region (2015-2020)
Table 19. Global Cancer Biomarkers Revenue Market Share by Region (2015-2020)
Table 20. North America Cancer Biomarkers Sales by Country (2015-2020) (K MT)
Table 21. North America Cancer Biomarkers Sales Market Share by Country (2015-2020)
Table 22. North America Cancer Biomarkers Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Cancer Biomarkers Revenue Market Share by Country (2015-2020)
Table 24. Europe Cancer Biomarkers Sales by Country (2015-2020) (K MT)
Table 25. Europe Cancer Biomarkers Sales Market Share by Country (2015-2020)
Table 26. Europe Cancer Biomarkers Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Cancer Biomarkers Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Cancer Biomarkers Sales by Region (2015-2020) (K MT)
Table 29. Asia Pacific Cancer Biomarkers Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Cancer Biomarkers Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Cancer Biomarkers Revenue Market Share by Region (2015-2020)
Table 32. Latin America Cancer Biomarkers Sales by Country (2015-2020) (K MT)
Table 33. Latin America Cancer Biomarkers Sales Market Share by Country (2015-2020)
Table 34. Latin America Cancer Biomarkers Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Cancer Biomarkers Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Cancer Biomarkers Sales by Country (2015-2020) (K MT)
Table 37. Middle East and Africa Cancer Biomarkers Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Cancer Biomarkers Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Cancer Biomarkers Revenue Market Share by Country (2015-2020)
Table 40. Global Cancer Biomarkers Sales (K MT) by Type (2015-2020)
Table 41. Global Cancer Biomarkers Sales Share by Type (2015-2020)
Table 42. Global Cancer Biomarkers Revenue (Million US$) by Type (2015-2020)
Table 43. Global Cancer Biomarkers Revenue Share by Type (2015-2020)
Table 44. Global Cancer Biomarkers Price (USD/MT) by Type (2015-2020)
Table 45. Global Cancer Biomarkers Sales (K MT) by Application (2015-2020)
Table 46. Global Cancer Biomarkers Sales Market Share by Application (2015-2020)
Table 47. Global Cancer Biomarkers Sales Growth Rate by Application (2015-2020)
Table 48. Abbott Laboratories Cancer Biomarkers Corporation Information
Table 49. Abbott Laboratories Description and Business Overview
Table 50. Abbott Laboratories Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 51. Abbott Laboratories Main Product
Table 52. Abbott Laboratories Recent Development
Table 53. Thermo Fisher Scientific Cancer Biomarkers Corporation Information
Table 54. Thermo Fisher Scientific Corporation Information
Table 55. Thermo Fisher Scientific Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 56. Thermo Fisher Scientific Main Product
Table 57. Thermo Fisher Scientific Recent Development
Table 58. F. Hoffmann-La Roche Ltd Cancer Biomarkers Corporation Information
Table 59. F. Hoffmann-La Roche Ltd Corporation Information
Table 60. F. Hoffmann-La Roche Ltd Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 61. F. Hoffmann-La Roche Ltd Main Product
Table 62. F. Hoffmann-La Roche Ltd Recent Development
Table 63. Illumina,Inc. Cancer Biomarkers Corporation Information
Table 64. Illumina,Inc. Corporation Information
Table 65. Illumina,Inc. Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 66. Illumina,Inc. Main Product
Table 67. Illumina,Inc. Recent Development
Table 68. Agilent Technologies Cancer Biomarkers Corporation Information
Table 69. Agilent Technologies Corporation Information
Table 70. Agilent Technologies Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 71. Agilent Technologies Main Product
Table 72. Agilent Technologies Recent Development
Table 73. Qiagen NV Cancer Biomarkers Corporation Information
Table 74. Qiagen NV Corporation Information
Table 75. Qiagen NV Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Qiagen NV Main Product
Table 77. Qiagen NV Recent Development
Table 78. Merck & Co. Cancer Biomarkers Corporation Information
Table 79. Merck & Co. Corporation Information
Table 80. Merck & Co. Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Merck & Co. Main Product
Table 82. Merck & Co. Recent Development
Table 83. Hologic,Inc. Cancer Biomarkers Corporation Information
Table 84. Hologic,Inc. Corporation Information
Table 85. Hologic,Inc. Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Hologic,Inc. Main Product
Table 87. Hologic,Inc. Recent Development
Table 88. Novartis AG Cancer Biomarkers Corporation Information
Table 89. Novartis AG Corporation Information
Table 90. Novartis AG Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Novartis AG Main Product
Table 92. Novartis AG Recent Development
Table 93. BioMerieux SA Cancer Biomarkers Corporation Information
Table 94. BioMerieux SA Corporation Information
Table 95. BioMerieux SA Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. BioMerieux SA Main Product
Table 97. BioMerieux SA Recent Development
Table 98. Genomic Health Cancer Biomarkers Corporation Information
Table 99. Genomic Health Corporation Information
Table 100. Genomic Health Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. Genomic Health Main Product
Table 102. Genomic Health Recent Development
Table 103. Affymetrix Cancer Biomarkers Corporation Information
Table 104. Affymetrix Corporation Information
Table 105. Affymetrix Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Affymetrix Main Product
Table 107. Affymetrix Recent Development
Table 108. Roche Diagnostics Ltd. Cancer Biomarkers Corporation Information
Table 109. Roche Diagnostics Ltd. Corporation Information
Table 110. Roche Diagnostics Ltd. Cancer Biomarkers Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. Roche Diagnostics Ltd. Main Product
Table 112. Roche Diagnostics Ltd. Recent Development
Table 113. Sales Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Cancer Biomarkers Distributors List
Table 116. Cancer Biomarkers Customers List
Table 117. Market Key Trends
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Global Cancer Biomarkers Sales (K MT) Forecast by Type (2021-2026)
Table 121. Global Cancer Biomarkers Sales Market Share Forecast by Type (2021-2026)
Table 122. Global Cancer Biomarkers Revenue (Million US$) Forecast by Type (2021-2026)
Table 123. Global Cancer Biomarkers Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 124. Global Cancer Biomarkers Sales (K MT) Forecast by Application (2021-2026)
Table 125. Global Cancer Biomarkers Revenue (Million US$) Forecast by Application (2021-2026)
Table 126. Global Cancer Biomarkers Sales (K MT) Forecast by Region (2021-2026)
Table 127. Global Cancer Biomarkers Sales Market Share Forecast by Region (2021-2026)
Table 128. Global Cancer Biomarkers Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Global Cancer Biomarkers Revenue Market Share Forecast by Region (2021-2026)
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Cancer Biomarkers
Figure 2. Global Cancer Biomarkers Sales Market Share by Type: 2020 VS 2026
Figure 3. Protein Biomarkers Product Picture
Figure 4. Genetic Biomarkers Product Picture
Figure 5. Others Product Picture
Figure 6. Global Cancer Biomarkers Consumption Market Share by Application: 2020 VS 2026
Figure 7. Breast Cancer
Figure 8. Lung Cancer
Figure 9. Colorectal Cancer
Figure 10. Melanoma
Figure 11. Blood Cancer
Figure 12. Prostate Cancer
Figure 13. Ovarian Cancer
Figure 14. Stomach Cancer
Figure 15. Liver Cancer
Figure 16. Global Cancer Biomarkers Market Size 2015-2026 (US$ Million)
Figure 17. Global Cancer Biomarkers Sales Capacity (K MT) (2015-2026)
Figure 18. Global Cancer Biomarkers Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Cancer Biomarkers Sales Share by Manufacturers in 2020
Figure 20. Global Cancer Biomarkers Revenue Share by Manufacturers in 2019
Figure 21. The Global 5 and 10 Largest Players: Market Share by Cancer Biomarkers Revenue in 2019
Figure 22. Cancer Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Cancer Biomarkers Sales Market Share by Region (2015-2020)
Figure 24. Global Cancer Biomarkers Sales Market Share by Region in 2019
Figure 25. Global Cancer Biomarkers Revenue Market Share by Region (2015-2020)
Figure 26. Global Cancer Biomarkers Revenue Market Share by Region in 2019
Figure 27. North America Cancer Biomarkers Sales Market Share by Country in 2019
Figure 28. North America Cancer Biomarkers Revenue Market Share by Country in 2019
Figure 29. U.S. Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 30. U.S. Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. Canada Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 32. Canada Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Europe Cancer Biomarkers Sales Market Share by Country in 2019
Figure 34. Europe Cancer Biomarkers Revenue Market Share by Country in 2019
Figure 35. Germany Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 36. Germany Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. France Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 38. France Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. U.K. Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 40. U.K. Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Italy Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 42. Italy Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Russia Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 44. Russia Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Asia Pacific Cancer Biomarkers Sales Market Share by Region in 2019
Figure 46. Asia Pacific Cancer Biomarkers Revenue Market Share by Region in 2019
Figure 47. China Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 48. China Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Japan Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 50. Japan Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. South Korea Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 52. South Korea Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. India Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 54. India Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Australia Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 56. Australia Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Taiwan Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 58. Taiwan Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Indonesia Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 60. Indonesia Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Thailand Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 62. Thailand Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Malaysia Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 64. Malaysia Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Philippines Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 66. Philippines Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Vietnam Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 68. Vietnam Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Latin America Cancer Biomarkers Sales Market Share by Country in 2019
Figure 70. Latin America Cancer Biomarkers Revenue Market Share by Country in 2019
Figure 71. Mexico Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 72. Mexico Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Brazil Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 74. Brazil Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Argentina Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 76. Argentina Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Middle East and Africa Cancer Biomarkers Sales Market Share by Country in 2019
Figure 78. Middle East and Africa Cancer Biomarkers Revenue Market Share by Country in 2019
Figure 79. Turkey Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 80. Turkey Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Saudi Arabia Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 82. Saudi Arabia Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. U.A.E Cancer Biomarkers Sales Growth Rate (2015-2020) (K MT)
Figure 84. U.A.E Cancer Biomarkers Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Sales Market Share of Cancer Biomarkers by Type (2015-2020)
Figure 86. Sales Market Share of Cancer Biomarkers by Type in 2019
Figure 87. Revenue Share of Cancer Biomarkers by Type (2015-2020)
Figure 88. Revenue Market Share of Cancer Biomarkers by Type in 2019
Figure 89. Global Cancer Biomarkers Sales Growth by Type (2015-2020) (K MT)
Figure 90. Global Cancer Biomarkers Sales Market Share by Application (2015-2020)
Figure 91. Global Cancer Biomarkers Sales Market Share by Application in 2019
Figure 92. Global Revenue Share of Cancer Biomarkers by Application (2015-2020)
Figure 93. Global Revenue Share of Cancer Biomarkers by Application in 2020
Figure 94. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Illumina,Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Qiagen NV Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Hologic,Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. BioMerieux SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Genomic Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Affymetrix Total Revenue (US$ Million): 2019 Compared with 2018
Figure 106. Roche Diagnostics Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Price Trend of Key Raw Materials
Figure 108. Manufacturing Cost Structure of Cancer Biomarkers
Figure 109. Manufacturing Process Analysis of Cancer Biomarkers
Figure 110. Cancer Biomarkers Industrial Chain Analysis
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Porter's Five Forces Analysis
Figure 114. North America Cancer Biomarkers Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 115. North America Cancer Biomarkers Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Europe Cancer Biomarkers Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 117. Europe Cancer Biomarkers Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Latin America Cancer Biomarkers Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 119. Latin America Cancer Biomarkers Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 120. Middle East and Africa Cancer Biomarkers Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 121. Middle East and Africa Cancer Biomarkers Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 122. Asia Pacific Cancer Biomarkers Sales (K MT) and Growth Rate Forecast (2021-2026)
Figure 123. Asia Pacific Cancer Biomarkers Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed